MicroRNA-146a down-regulation correlates with neuroprotection and targets pro-apoptotic genes in cerebral ischemic injury in vitro

Brain Res. 2016 Oct 1;1648(Pt A):136-143. doi: 10.1016/j.brainres.2016.07.034. Epub 2016 Jul 20.

Abstract

MicroRNAs (miRNAs) are short, non-coding RNAs that negatively regulate target gene expression, and play an important role in cerebral ischemic injury. MiR-146a has been reported to be highly related to cell invasion, metastasis, immunity, inflammation and apoptosis. Previous studies have indicated that miR-146a can either inhibit or promote apoptosis through different pathophysiological processes. In our previous study, miR-146a in the blood was down-regulated during acute ischemic stroke. However, the connection between miR-146a and acute cerebral ischemic injury and the mechanism underlying the connection remain unclear. Here, we aimed to investigate the role of miR-146a and its possible target genes in human SK-N-SH cells subjected to 16h of oxygen-glucose deprivation and 12h of reperfusion (OGD/R) injury. Cells were transfected with miR-146a mimic or inhibitor to alter the expression of miR-146a. MiR-146a in the SK-N-SH cells was down-regulated after OGD/R injury. Moreover, bioinformatics analysis and dual luciferase assays demonstrated that miR-146a directly recognized the 3'-UTR of the pro-apoptotic genes, Caspase7 and Bcl-2-associated transcription factor 1 (Bclaf1). Furthermore, miR-146a over-expression effectively decreased the mRNA and protein expression of Caspase7 and Bclaf1, and aggravated OGD/R-induced cell apoptosis; in contrast, miR-146a down-regulation was neuroprotective. In conclusion, our study revealed that miR-146a contributes to OGD/R injury in vitro, while negatively regulating the pro-apoptotic genes, Caspase7 and Bclaf1. This special mechanism provides new insight into miRNA regulatory networks. In addition, miR-146a may offer a potential therapeutic approach to cerebral ischemic injury.

Keywords: Apoptosis; Cerebral ischemic injury; MicroRNA-146a; Oxygen-glucose deprivation and reperfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions
  • Apoptosis
  • Brain Ischemia / pathology*
  • Brain Ischemia / therapy
  • Caspase 7 / metabolism
  • Cell Culture Techniques
  • Cell Hypoxia / physiology
  • Cell Line, Tumor
  • Down-Regulation
  • Glucose / metabolism
  • HEK293 Cells
  • Humans
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism*
  • Neurons / metabolism
  • Neuroprotection
  • Neuroprotective Agents
  • Oxygen / metabolism
  • Repressor Proteins
  • Stroke / pathology
  • Tumor Suppressor Proteins

Substances

  • 3' Untranslated Regions
  • BCLAF1 protein, human
  • MIRN146 microRNA, human
  • MicroRNAs
  • Neuroprotective Agents
  • Repressor Proteins
  • Tumor Suppressor Proteins
  • Caspase 7
  • Glucose
  • Oxygen